NCT03246386View on ClinicalTrials.gov

Dosing Obese With Noxafil® Under a Trial (DONUT)

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 5, 2017

Primary Completion Date

September 1, 2018

Study Completion Date

September 1, 2018

Conditions
Morbid Obesity
Interventions
DRUG

Posaconazole Injection [Noxafil] 300mg

Single dose by intravenous infusion 300mg

DRUG

Posaconazole Injection [Noxafil] 400mg

Single dose by intravenous infusion 400mg

Trial Locations (2)

Unknown

St. Antonius hospital, Nieuwegein

Radboudumc, Nijmegen

All Listed Sponsors
collaborator

St. Antonius Hospital

OTHER

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Radboud University Medical Center

OTHER

NCT03246386 - Dosing Obese With Noxafil® Under a Trial (DONUT) | Biotech Hunter | Biotech Hunter